2022 Q1 Report
Release Date: 5/13/2022 8:00:11 AM
IRIS Code: BB56A
Notice of availability for the Report on 31 March 2022
Antibiotice Iasi informs the investors that the report on 31.03.2022 is available through the Bucharest Stock Exchange and Financial Surveillance Authority as well as on our website: www.antibiotice.ro (Investors/Financial Information/Financial Reports - 2022, 3 months).
We mention that the above-mentioned report can also be obtained at our company’s headquarters (Investor Relations, phone no. 0232 209570, fax 0372 065633,e-mail: email@example.com).
ec. Paula-Luminita COMAN
Information provided by IRIS, the news platform of the Bucharest Stock Exchange.
Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item.
Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB.
Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
©2016 Bucharest Stock Exchange. All rights reserved